Patents by Inventor John E. Kuleza

John E. Kuleza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040097864
    Abstract: By providing an integrated, easily employed holding or support member which is uniquely constructed for cooperating with a heat delivery patch or exothermic pad for optimizing the application of heat directly to a precisely desired location, a local, easily employed, convenient, consumer oriented treatment system for providing heat therapy for a wide variety of medical problems is achieved. In accordance with the present invention, a fully integrated treatment system is realized which possesses broad applicability for a wide range of medical conditions which can be treated or improved by heat penetration into the skin, subcutaneous tissues, joints, muscles, blood streams, etc. In addition, it has also been found that the delivery of drugs, penetration enhancing agents and/or cosmetics through the skin for the purpose of achieving a non-oral and/or non-parenteral, systemic, transdermal delivery is effectively enhanced by the presence of a controlled heat gradient.
    Type: Application
    Filed: July 1, 2003
    Publication date: May 20, 2004
    Inventors: Israel Dvoretzky, John E. Kuleza
  • Publication number: 20010049546
    Abstract: By providing an integrated, easily employed holding or support member which is uniquely constructed for cooperating with a heat delivery patch or exothermic pad for optimizing the application of heat directly to a precisely desired location, a local, easily employed, convenient, consumer oriented treatment system for providing heat therapy for a wide variety of medical problems is achieved. In accordance with the present invention, a fully integrated treatment system is realized which possesses broad applicability for a wide range of medical conditions which can be treated or improved by heat penetration into the skin, subcutaneous tissues, joints, muscles, blood streams, etc. In addition, it has also been found that the delivery of drugs, penetration enhancing agents and/or cosmetics through the skin for the purpose of achieving a non-oral and/or non-parenteral, systemic, transdermal delivery is effectively enhanced by the presence of a controlled heat gradient.
    Type: Application
    Filed: January 8, 2001
    Publication date: December 6, 2001
    Inventors: Israel Dvoretzky, John E. Kuleza
  • Patent number: 5534021
    Abstract: By providing a carrier constructed for securely retaining a heat generating pad while also being able to be easily, securely mounted to the skin surface of an individual, a delivery system is achieved for providing heat therapy to any desired site or location. The heat generating pad is securely retained using either permanent or separatable fastening means. By employing separatable fastening means, the same carrier can be repeatedly employed by changing to a new heat generating pad after the previously used pad is exhausted. In addition, the carrier incorporates either adhesive means for mounting the carrier and pad to a user or employs separatable fastening means mounted to the carrier to enable the carrier and pad to be easily positioned, wherever desired, and securely retained in that position by engaging the fastening means.
    Type: Grant
    Filed: September 1, 1994
    Date of Patent: July 9, 1996
    Inventors: Israel Dvoretzky, John E. Kuleza
  • Patent number: 5248494
    Abstract: A lenitive composition is provided for application to the skin of an anthralin patient for reducing anthralin-induced inflammation and the staining associated with anthralin use. The lenitive composition is a single phase aqueous treating solution comprising an organic amine and a film-forming agent dissolved within a nontoxic dermatologically acceptable carrier. The organic amine is selected from the group consisting of lower alkyl and lower alkanol primary, secondary and tertiary amines and comprises about 1 to 25 percent by weight of the single phase aqueous treating solution. The solution is topically applied to the anthralin-treated areas so as to completely cover the treated areas. The solution is applied before or after anthralin wash off, preferably in the form of a fine spray or mist.
    Type: Grant
    Filed: June 10, 1992
    Date of Patent: September 28, 1993
    Assignee: Young Pharmaceuticals Inc.
    Inventors: John E. Kuleza, Lawrence Clifford M., Sam Shuster